128 related articles for article (PubMed ID: 6380398)
1. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
[TBL] [Abstract][Full Text] [Related]
2. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
Dilley WG; Leight GS; Silva JS; Ammirata S; Haagensen DE; Wells SA
J Natl Cancer Inst; 1983 Jan; 70(1):69-74. PubMed ID: 6571924
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
Surg Forum; 1978; 29():162-4. PubMed ID: 401123
[TBL] [Abstract][Full Text] [Related]
4. Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.
Dilley WG; Haagensen DE; Leight GS; Ammirata S; Davis SR; Silva JS; Zamcheck N; Lokich JJ; Wells SA
Breast Cancer Res Treat; 1986; 8(3):205-15. PubMed ID: 3593986
[TBL] [Abstract][Full Text] [Related]
5. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
[TBL] [Abstract][Full Text] [Related]
6. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
[TBL] [Abstract][Full Text] [Related]
7. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
Collette J; Hendrick JC; Jaspar JM; Franchimont P
Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
[TBL] [Abstract][Full Text] [Related]
8. Biochemical correlates of morphologic differentiation in human breast cancer.
Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
10. Immunoperoxidase staining for tumor markers in patients with carcinoma of the breast.
Cox CE; Haagensen DE; Dilley WG; Wells SA
Surg Forum; 1978; 29():160-2. PubMed ID: 401405
[No Abstract] [Full Text] [Related]
11. Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
Chalbos D; Haagensen D; Parish T; Rochefort H
Cancer Res; 1987 Jun; 47(11):2787-92. PubMed ID: 3567903
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F
Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533
[TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
[TBL] [Abstract][Full Text] [Related]
14. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.
Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
[TBL] [Abstract][Full Text] [Related]
17. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
18. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
[TBL] [Abstract][Full Text] [Related]
19. Tumor markers for breast carcinoma.
Haagensen DE
Clin Lab Med; 1982 Sep; 2(3):543-65. PubMed ID: 6754225
[No Abstract] [Full Text] [Related]
20. Metastatic breast carcinoma presenting as endometrial cancer. A case report.
Lallas TA; Taskin M; Calanog A; Shevchuk MM
J Reprod Med; 1997 Feb; 42(2):121-3. PubMed ID: 9058349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
